Extend Biosciences

Screenshot 2019-03-11 12.57.38.png

Extend Biosciences Inc. is an emerging biotechnology company developing a novel drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins.


Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value.


Their proprietary D-VITylation® platform technology significantly improves the circulating half-life and bioavailability of peptides and proteins, enabling the development of potent and specific drugs.